Vireo Growth三季度GAAP营收2.537亿美元同比增177%：备考营收2.77亿美元，季末现金1.068亿美元
Vireo Growth于2026年11月10日在明尼苏达州明尼阿波利斯公布截至2026年9月30日的第三财季业绩。第三季度按美国通用会计准则的营收为2.537亿美元，同比增长177%，公司称增长由近期完成的并购交易驱动。
按备考口径，第三季度营收为2.77亿美元，该口径假设C21 Investments、PharmaCann科罗拉多州部分资产与大麻业务The Cannabist科罗拉多州资产的收购均于2026年7月1日完成。其中GAAP大麻营收为1.981亿美元，非大麻营收为5560万美元。
公司称，按第三季度GAAP营收计算，其年化营收运行率已超过10亿美元。第三季度末公司持有现金1.068亿美元，并已启动股份回购计划，同时通过新银行伙伴扩大融资能力。
业绩电话会定于11月10日东部时间上午8时举行。公司在展望中计入自2026年11月9日起并入的FLUENT，未计入尚待完成的收购。
（来源：Vireo Growth）
Vireo Growth Third-Quarter GAAP Revenue Jumps 177 Percent to $253.7 Million, With Pro Forma Revenue of $277.0 Million and $106.8 Million Cash
Vireo Growth reported results for its third fiscal quarter ended September 30, 2026, in Minneapolis, Minnesota, on November 10, 2026. GAAP revenue was $253.7 million, up 177 percent year over year, driven, the company said, by recently closed merger and acquisition transactions.
Pro forma revenue was $277.0 million, giving effect to the acquisitions of C21 Investments, certain PharmaCann Colorado assets and the Cannabist Colorado assets as if they were completed on July 1, 2026. GAAP cannabis revenue was $198.1 million and GAAP non-cannabis revenue was $55.6 million.
The company said its annualized revenue run rate exceeded $1 billion based on third-quarter GAAP revenue. It closed the quarter with $106.8 million in cash, launched a share repurchase program and expanded financing capacity with new banking partners.
The results call was scheduled for 8:00 a.m. Eastern Time on November 10. The outlook includes FLUENT from November 9, 2026, and excludes pending acquisitions.
(Source: Vireo Growth)
来源：Vireo Growth
发布：GSM·美国（发布链接）
图片来源：图：室内大麻种植（资料图）。照片：CC BY-SA 4.0，经 Wikimedia Commons。 / Photo: Indoor cannabis cultivation (file photo). CC BY-SA 4.0, via Wikimedia Commons.
GSM Global · 本篇英文版 English edition of this story
